Syros Pharmaceuticals, a Cambridge, Mass.-based cancer drug developer, relied on Ten Bridge Communications and Stern IR for support through its July 6 IPO.
Syros raised $57.5M with the Nasdaq listing, short of projections. The funds will be used to fund its drug trials focused on controlling genes that cause cancer.
Ten Bridge partner Naoi Aoki leads the PR account at her firm, which was founded by Feinstein Kean Healthcare alums Dan Quinn and Ann Stanesa.
Stern senior associate Jesse Baumgartner reps Syros at the IR firm.
Teneo is handling the initial public offering of CVC Capital Partners, one of Europe’s largest private equity firms with nearly $200B in assets under management.
Brunswick Group represents Endeavor Group Holdings as it agrees to go private via its acquisition by Silver Lake technology investment firm, which is handled by Edelman Smithfield.
Tod Donhauser, a nine-year veteran of Edelman, has joined H/Advisors Abernathy as managing director and head of its San Francisco office.
Intelligent Group Ltd, a Hong Kong-based financial PR firm, has priced its initial public offering of 1.9M shares at $4, which is the low end of the $4 to $5 range.
Kekst CNC represents Grant Thornton as it sells a majority stake in its US arm to New Mountain Capital, which relies on Goldin Solutions, in what is billed as the largest PE investment in the accounting and advisory sector.
Have a comment? Send it to 
No comments have been submitted for this story yet.